Canaccord raised the firm’s price target on Illumina (ILMN) to $105 from $99 and keeps a Hold rating on the shares. The firm noted they reported 2Q25 results that were ahead of firm estimates and FactSet consensus. The target increase is driven by increased revenue in 2025 and beyond as well as modestly higher operating margin expansion.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ILMN:
- Illumina price target raised to $90 from $85 at Barclays
- Illumina’s Strategic Concerns and Uncertain Outlook: Sell Rating Reiterated with Lowered Price Objective
- Illumina’s Q2 2025 Earnings and Strategic Moves
- Hold Rating on Illumina Amid Strong Performance and Market Challenges
- Closing Bell Movers: Apple up 2%, Amazon down over 6% after results